New research: what worked and what didn't

January 2009
CMAJ: Canadian Medical Association Journal;1/6/2009 Conference Reports, p4
Academic Journal
The article offers information on developments and updates on tools and methods in assessing and managing cardiovascular risk. Results of significant clinical trials were unveiled at the 2008 American Heart Association meeting. It is found that early and late intervention are both safe an effective for those without ST-elevation myocardial infarction (STEMI). IT is mentioned that regular intake of vitamin C and vitamin E supplements fail to protect against cardiovascular disease incident. The therapeutic potential of new oral anticoangulant ATLAS ACS-TIMI 46 trial.


Related Articles

  • WHY SOME STATINS WORK BETTER.  // Time;9/13/2004, Vol. 164 Issue 11, p105 

    Mentions the findings that high doses of the cholesterol-lowering statin drug Lipitor lowered patients' levels of bad cholesterol and reduced their risk for heart attack. Results for patients who took the drug Zocor, a statin which does not reduce inflammation as well as Lipitor; Consideration...

  • Assessing cardiac risk factors: is a rethink in order?  // CMAJ: Canadian Medical Association Journal;1/6/2009 Conference Reports, p1 

    The article offers information on developments and updates on tools and methods in assessing and managing cardiovascular risk. The American Heart Association released the risk markers and appropriate use of statins. It is argued that the use of statin can reduce the prevalence of cardiovascular...

  • JUPITER lights up New Orleans sky.  // CMAJ: Canadian Medical Association Journal;1/6/2009 Conference Reports, p3 

    The article offers information on developments and updates on tools and methods in assessing and managing cardiovascular risk. The American Heart Association released the therapeutic use of statin and the use of high-sensitivity C-reactive protein. It is mentioned that the use of statin can...

  • Study Finds Warning Signs May Predict Sudden Cardiac Arrest.  // Heart Advisor;Mar2016, Vol. 18 Issue 3, p3 

    The article presents the research that investigates the warning signs that can forecast sudden cardiac arrest (SCA) in the U.S. The topics discussed include the symptoms of heart disease, risk factors and ways of responding to the symptoms. Moreover, it also cites the difference between SCA and...

  • QRS Fragmentation Patterns Representing Myocardial Scar Need to Be Separated from Benign Normal Variants: Hypotheses and Proposal for Morphology based Classification. Haukilahti, M. Anette E.; Eranti, Antti; Kenttä, Tuomas; Huikuri, Heikki V. // Frontiers in Physiology;12/26/2016, Vol. 7, p1 

    The presence of a fragmented QRS complex (fQRS) in two contiguous leads of a standard 12-lead electrocardiogram (ECG) has been shown to be an indicator of myocardial scar in multiple different populations of cardiac patients. QRS fragmentation is also a predictor of adverse prognosis in acute...

  • Lower incidence of CHD, other vascular events observed with absolute reductions in LDL-C.  // Formulary;Jan2006, Vol. 41 Issue 1, p35 

    The article reports that absolute reductions in low density lipoproteins-C reduce the incidence of coronary heart disease and other major vascular events through statin therapy. The prospective meta-analysis of data was largely irrespective of the initial lipid profile. There were corresponding...

  • Clinical Significance of Pleiotropic Effects of Statins: Lipid Reduction and Beyond. Auer, J.; Berent, R.; Weber, T.; Eber, B. // Current Medicinal Chemistry;Oct2002, Vol. 9 Issue 20, p1831 

    Statins significantly reduce cardiovascular-related morbidity and mortality in patients with and without coronary artery disease. The potential of this drug class has yet to be fully explored. Accumulating evidence from basic research and clinical trials indicates that statins have pleiotropic...

  • Coronary Artery Disease -- Myocardial Infarction.  // Current Medical Literature: Interventional Cardiology Monitor;2005, Vol. 12 Issue 2, p55 

    Presents various research studies on myocardial infarction, a coronary artery disease. "Effect of Statin Therapy Prior to Elective Percutaneous Coronary Intervention on Frequency of Periprocedural Myocardial Injury"; Demonstration of the safety of routine percutaneous coronary intervention...

  • Cardioprotective role of statins in chronic kidney disease: do we have the answer? Fellström, Bengt C // Kidney International;May2011, Vol. 79 Issue 9, p931 

    The observational study by Szummer et al. shows that patients with advanced chronic kidney disease (CKD) are treated less with statins after myocardial infarction, even though statins benefit survival in CKD classes 1-4. The study's limitations are obvious, but such a population may be more...


Read the Article


Sign out of this library

Other Topics